What is this combination used for?

To improve blood sugar control in type 2 diabetes when monotherapy is insufficient.

How do Empagliflozin and Linagliptin work together?

Empagliflozin increases glucose elimination via urine; Linagliptin enhances insulin secretion.

Can this medication cause weight gain?

No, it is weight-neutral or may cause mild weight loss.

When should I take this medication?

Once daily, preferably in the morning, with or without food.

Can it be combined with insulin or other drugs?

Yes, but only under medical supervision to adjust doses safely.

Empagliflozin 25mg + Linagliptin 5mg IR Tablet | Intralife Pharmaceuticals

Name: Empasug-LG 25mg
Brand: Intralife
SKU: -OJF7lEeAVvWryM-jKg4
Price: 2 INR
Availability: InStock

Empasug-LG 25mg

MRP: 2

Packaging: 10X10

Pack Type: tablet

Composition:

Empagliflozin 25 mg + Linagliptin 5 mg IR

Indication:

Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. This combination of SGLT2 inhibitor (Empagliflozin) and DPP-4 inhibitor (Linagliptin) provides dual glucose-lowering effects. Not for type 1 diabetes or diabetic ketoacidosis.

Description:

Empagliflozin 25mg + Linagliptin 5mg IR is a potent fixed-dose combination tablet used for managing type 2 diabetes mellitus. This combination harnesses the benefits of two distinct antidiabetic agents:

Empagliflozin (25mg): A Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor that reduces blood glucose by promoting its elimination through urine.
Linagliptin (5mg): A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that improves blood sugar control by enhancing insulin secretion and lowering glucagon levels in a glucose-dependent manner.

The higher 25mg dose of Empagliflozin is prescribed for patients who need intensified glycemic control beyond the 10mg dose. This combination offers effective blood sugar management with additional cardiovascular and renal protective effects, making it ideal for patients with multiple comorbidities. The immediate-release formulation ensures rapid onset of action for better glucose regulation.

Tags:

Type 2 Diabetes Combination Therapy SGLT2 Inhibitors DPP-4 Inhibitors Oral Antidiabetics Immediate Release Prescription Medicines

Usage Information

Dosage

Take one tablet once daily, preferably in the morning. Can be taken with or without food. Dosage adjustments should be made by your healthcare provider. Maintain adequate hydration during therapy.

Side Effects

Common side effects: Increased urination Genital yeast infections Upper respiratory infections Thirst and dehydration Mild gastrointestinal upset Serious but rare side effects: Diabetic ketoacidosis Acute kidney injury Severe allergic reactions Hypotension (low blood pressure) Rare soft tissue infections (Fournier’s gangrene)

Contraindications

Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment (eGFR < 30 mL/min/1.73m²) Hypersensitivity to Empagliflozin, Linagliptin, or excipients History of pancreatitis (use with caution) Volume depletion or dehydration